Osteolytic Mechanisms in Total Joint Arthroplasty

Total joint arthroplasty has revolutionised the treatment of end-stage joint disease, yet long-term implant survival remains challenged by aseptic loosening driven by periprosthetic osteolysis. Mechanical wear of bearing surfaces generates particulate debris that provokes an innate immune response at the bone–implant interface. Phagocytosis of these particles by macrophages and other monocytic cells initiates a cascade of pro-inflammatory cytokine release, notably tumour necrosis factor-α, interleukin-1β and interleukin-6, which in turn upregulate receptor activator of nuclear factor κB ligand (RANKL). Excessive RANKL signalling drives osteoclast differentiation, activation and survival, tipping the balance towards bone resorption. Additional contributions from local mechanical micromotion, fluid pressure fluctuations and synovial-like membrane formation exacerbate osteolytic resorption. Advances in imaging and molecular markers have begun to improve early detection, while novel therapeutic approaches aim to modulate inflammatory pathways, inhibit osteoclastogenesis or promote osteoblast-mediated bone formation. A deeper understanding of the cellular and molecular interplay underpinning osteolysis is essential to extend implant longevity and reduce the burden of revision surgery worldwide.

Research from Nature Portfolio

One study demonstrated that strontium supplementation can significantly mitigate particle-induced bone loss by inhibiting osteoclast activation and attenuating inflammatory infiltration in a murine calvarial model. Mechanistically, strontium was shown to disrupt RANKL-mediated NF-κB signalling within bone-marrow-derived macrophages, reducing pro-inflammatory cytokine expression and osteoclastic bone resorption in a dose-dependent manner. In parallel, foundational work on a bioactive flavonoid revealed that icariin promotes osteogenic differentiation of mesenchymal stem cells at sites of titanium-particle-induced osteolysis. This effect was achieved through stabilisation of β-catenin and activation of the Wnt/β-catenin pathway, leading to enhanced mineralisation in vitro and increased bone formation in vivo. These investigations highlight the therapeutic promise of targeting both inflammatory and regenerative pathways to counteract periprosthetic bone loss.

Osteolytic Mechanisms in Total Joint Arthroplasty publication trend

The graph below shows the total number of articles in osteolytic mechanisms in total joint arthroplasty across all publications each year (not limited to Nature Index journals).

Technical terms

Osteolysis: Pathological bone resorption occurring around an implant, often leading to aseptic loosening.

Wear particles: Microscopic debris generated by mechanical articulation of prosthetic components, composed of metals, polymers or ceramics.

Osteoclastogenesis: The differentiation and activation of osteoclasts, specialised cells responsible for bone resorption, primarily driven by RANKL signalling.

RANKL: A cytokine (receptor activator of nuclear factor κB ligand) essential for osteoclast formation, survival and activation.

Macrophage polarization: The process by which macrophages adopt pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes in response to local stimuli.

References

1. Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failure. Aggregate (2024).
2. Osteoblasts-derived exosomes as potential novel communicators in particle-induced periprosthetic osteolysis. Materials Today Bio (2024).
3. Metabolic profile of mesenchymal stromal cells and macrophages in the presence of polyethylene particles in a 3D model. Stem Cell Research & Therapy (2023).
4. Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-κB pathway. Scientific Reports (2016).
5. Icariin attenuates titanium-particle inhibition of bone formation by activating the Wnt/β-catenin signaling pathway in vivo and in vitro. Scientific Reports (2016).